New tests recommended by the WHO can address TB cases with no or few symptoms more quickly and improve access to life-saving treatment.
Tuberculosis can recur through relapse or new drug-resistant strains, often triggered by incomplete treatment, a weakened ...
For decades, patients being treated for drug-resistant tuberculosis have had to endure a gruelling regimen of daily injections and a cocktail of drugs with severe side effects.
On World TB Day, the World Health Organization (WHO) is urging countries to accelerate action to end tuberculosis (TB) and ...
Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...
Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...
Clinical Trials Arena on MSN
Trials to watch: Phase III TB vaccines and MDR-TB treatments
GlobalData epidemiologists project TB cases across the 16 major markets to reach 4.5 million by 2033.
A recently released prospective analysis of the first eight years of the Johns Hopkins Medicine-led Zero TB in Kids program ...
This World Tuberculosis (TB) Day, Médecins Sans Frontières (MSF) urges governments and international donors to bring children to the heart of the global TB response, and commit to investing in the ...
India Launches World's 1St Clinical Trial To Test Ayurveda With TB Treatment. New Delhi, March 24 (IANS) On the occasion of ...
Fiji’s TB treatment success rate remains 59 per cent, well below the global target of 90 per cent, officials say.
With new guidance from the World Health Organization (WHO), food and proper nourishment are now seen as key parts of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results